The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.

Clinical nephrology

Volumn 58 Suppl 1, Issue , 2002, Pages

  Silverberg, D S ^a   Wexler, D ^a   Blum, M ^a   Tchebiner, J ^a   Sheps, D ^a   Keren, G ^a   Schwartz, D ^a   Baruch, R ^a   Yachnin, T ^a   Shaked, M ^a   Zubkov, A ^a   Steinbruch, S ^a   Iaina, A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC ION; FERRIC OXIDE, SACCHARATED; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG COMBINATION; FEMALE; HEART STROKE VOLUME; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANEMIA; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KIDNEY FAILURE, CHRONIC; MALE; OXYGEN CONSUMPTION; STROKE VOLUME;

EID: 0036653582     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)